Nutritional Health Supplements

Dailyzyme
Vitalzym

Vitalzym X
TumorX 103
SerraEzyme
Digestive 150
Probiotic 14
Myomin

Other BioAnue Products

Cardiovascular Mender
Heart Mender
Stroke Mender
Alzehemirs Mender

Systemic enzymes
for chronic
health conditions

Cancer

Fibromyalgia

Cystic Fibrosis (CF)

Anti-Aging

Cardiovascular Disease

Fibrocystic Breast Disease

Asthma

Sinusitis

Sports Injuries

Related Links

TheHeart.org

StrokeAssociation.org

Sinusitis & Systemic Enzymes

What is Sinusitis?

Sinusitis is an infection that can occur either in the maxillary sinuses, which lie on both sides, deep in the face below the eyes, or the frontal sinuses, situated on either side of the bridge of the nose.

How does Sinusitis occur?

Invariably they are the result of intolerance to foods such as wheat and dairy products. A bowl dysfunction such as constipation (not passing stools 2-3 times per day) will contribute. Not drinking enough water 8 glasses per day (as opposed to tea, coffee and soft drinks) will also be implicated. Poor diet is absolutely implicated. This leads to a build-up of unhealthy tissue and provides a perfect breeding ground for infections.

How can Systemic Enzymes Help?

Systemic Enzymes…containing Serrapeptase helps immensely as it clears out all of the inflammation and mucus. By clearing away this problem tissue it enables the bodies own immune system to deal more easily with the infection.

How many would I take? Please call or email us for dosing and product recommendation.

Can I take too many tablets or can it interfere with any drugs?

No. It has been used for over 25 years with no side effects reported.
Research has shown a - 400% Improvement with the use of systemic enzyme blends containing Serrapeptase.

In a double-blind study, 193 subjects suffering from acute or chronic ear, nose or throat disorders were evaluated. Treatment with Serrapeptase lasted 7-8 days with 5 mg tabs. After 3-4 days treatment, significant symptom regression was observed in the Serrapeptase-treated group, while this was not noted in the control group. Patients suffering from laryngitis, catarrhal rhinopharyngitis and sinusitis noted markedly rapid improvement. The physicians' assessments of efficacy of treatment were excellent or good for 97.3% of patients treated with Serrapeptase, compared with only 21.9% of those treated with placebo.

Mizukoshi, D. et al. A double blind clinical study of Serrapeptase, in the treatment of chronic sinusitis. Igaku Ayrni 109:50-62.1979.

We hope you found this information to be informative. If you have any further questions please feel free to contact us.

Quality Enzymes

*These statements have not been evaluated by the U.S. Food and Drug Administration. The product is not intended to diagnose, treat, cure, or prevent any disease.